ALYSSA ANDERSON: Open Payments
NPI 1336421171 · BRANFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 106 payments from 17 companies in 2025. Trend: 2023 $1,463 · 2024 $1,140 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $422 |
| ABBVIE INC. | 31 | $393 |
| Novo Nordisk Inc | 9 | $183 |
| PFIZER INC. | 11 | $169 |
| GlaxoSmithKline, LLC. | 9 | $138 |
| Amgen Inc. | 7 | $138 |
| Lilly USA, LLC | 5 | $111 |
| Exact Sciences Corporation | 3 | $83 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| Indivior Inc. | 2 | $50 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, Wegovy, QULIPTA, UBRELVY, FARXIGA, TRELEGY ELLIPTA.
Industry payments across CT — which companies pay providers there.
